KHSV(-) EBV(-) post-transplant effusion lymphoma with plasmablastic features: variant of primary effusion lymphoma?

Hematol Oncol. 2009 Dec;27(4):203-10. doi: 10.1002/hon.892.

Abstract

Primary effusion lymphoma (PEL) is a rare type of B-cell non-Hodgkin lymphoma (NHL), which predominantly occurs in HIV-infected individuals, and is pathogenetically linked with Kaposi sarcoma (KS)-associated herpes virus/human herpes virus-8 (KSHV/HHV-8) infection with or without evidence of Epstein-Barr virus (EBV) co-infection. Although uncommon, PELs have been reported in immunocompetent patients and recipients of solid organ allografts. Rare cases of KSHV(-) EBV(+) post-transplant effusion lymphomas resembling PEL have also been described, as have KSHV(-) EBV(-) effusion lymphomas, the latter including those arising in individuals with chronic liver disease. We report a unique KSHV(-) EBV(-) post-transplant effusion lymphoma associated with serum paraproteins, occurring in an HIV(-) individual, which had cytologic features and phenotype similar to PEL, and displayed a complex karyotype including isochromosome 12p and translocation t(8;22), resulting in rearrangement of c-MYC.

Publication types

  • Case Reports

MeSH terms

  • Epstein-Barr Virus Infections / genetics
  • Epstein-Barr Virus Infections / pathology
  • Herpesvirus 4, Human / isolation & purification
  • Herpesvirus 8, Human / isolation & purification
  • Humans
  • Immunophenotyping
  • Liver Transplantation
  • Lymphoma, Primary Effusion / genetics
  • Lymphoma, Primary Effusion / pathology*
  • Lymphoma, Primary Effusion / virology
  • Male
  • Middle Aged
  • Plasma Cells / pathology
  • Sarcoma, Kaposi / genetics
  • Sarcoma, Kaposi / pathology
  • Sarcoma, Kaposi / virology